Fundraising Fox
/Companies
Sign in

Regentis

Herzliya, IL · 1 known investors

Find your way into Regentis

Sign up to see every warm intro you have to Regentis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Regentis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]

BiotechHealthtechMedical Devices

Founders & leadership

GR
Galit ReskeExecutive
AG
Arie GordashnikovExecutive
OGOri Gon
Ori GonExecutive

Board

JDJeff Dykan
Jeff DykanBoard directorPartner at SCP Vitalife Partners
EG
Ehud GellerBoard director
SA
Susan AlpertBoard director
PB
Pini Ben-ElazarBoard director
KV
Keith ValentineBoard director
EC
Efraim Cohen-AraziBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$6.5M disclosed across 1 round · 2026

▶$6.5MraisedJun 2026 · 22 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Galit ReskeExecutive Officer
  • Arie GordashnikovExecutive Officer
  • Susan AlpertDirector
  • Pini Ben-ElazarDirector
  • Keith ValentineDirector
  • Efraim Cohen-AraziDirector
  • Jeff DykanDirector
  • Ori GonExecutive Officer
  • Ehud GellerExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$6.5M
Sales commissions
$455K
Placement agents
ThinkEquity LLC
First sale
Jun 2026
Incorporated
Corporation, Israel
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.

Companies working in the same space as Regentis.

In the news

Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracksfinance.yahoo.com · Aug 2026

Frequently asked questions

What does Regentis do?
Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]
Who are Regentis's investors?
Regentis's investors include SCP Vitalife Partners.
How much funding has Regentis raised?
Regentis has disclosed $6.5M raised across 1 round.
Where is Regentis headquartered?
Regentis is headquartered in Herzliya, IL.